Azumio
For individuals living with diabetes who require both digital tracking tools and professional human support to manage their condition effectively.
Glucose Buddy Diabetes Tracker
Snapshot
Who is Azumio?
Providing comprehensive diabetes management through integrated data logging, hardware connectivity, and professional coaching.
Target audience
Portfolio
Free 5Last updated
Glucose Buddy Diabetes Tracker
v5.442
4mo ago
Publisher DNA
What defines Azumio?
Publisher DNA
Primary focus
Medical · Diabetes management platforms
Scale
indie
Target audience
Individuals living with diabetes who require both digital tracking tools and professional human support to manage their condition effectively.
Portfolio momentum
Released 2 updates across 2 apps in the last 6 months, maintaining a 100% active portfolio.
Portfolio
What does Azumio ship?
Apps
7 apps analysed
Analysis in progress
Analysis in progress
Analysis in progress
Track blood glucose, A1C, carbs, medication, exercise, and more all in one app!
Consolidated dashboard reduces cognitive load for multi-metric tracking
- Long-term users value the comprehensive tracking of glucose, blood pressure, and weight in one location
- Critical stability issues post-update cause the application to freeze or display a blank loading screen
Clinical-grade PDF reporting for healthcare providers
- Tracking blood sugar and medication logs provides essential health management for daily users
- Aggressive paywall transitions restrict access to previously free historical data and insights
Distributed across 19 markets, strongest in Europe.
Based on 2 of 7 apps with localized market data, more coverage rolling in as scans complete · last scanned .
Americas (4)
- Brazil2 / 2
- Canada2 / 2
- Mexico2 / 2
- United States2 / 2
Europe (8)
- France2 / 2
- Germany2 / 2
- Italy2 / 2
- Portugal2 / 2
- Spain2 / 2
›+3 more europe markets
- Sweden2 / 2
- Turkey2 / 2
- United Kingdom2 / 2
Asia-Pacific (7)
- Australia2 / 2
- India2 / 2
- Indonesia2 / 2
- Japan2 / 2
- Singapore2 / 2
›+2 more asia-pacific markets
- South Korea2 / 2
- Vietnam2 / 2
Core markets (2/2 apps)
User Sentiment
How do users feel about their apps?
0
Positive apps
0
Neutral / mixed
2
Negative apps
30/100
Avg sentiment score
Unlock the app dragging this portfolio down.
Access the full report for freeRivals
Who does Azumio compete with?
The rivals identified
Nemeses(1)
With over 134,000 reviews and a high-velocity release cadence, mySugr is the dominant direct competitor in the diabetes logging space.
Contenders(3)
Dominates the CGM-specific niche, serving as a critical utility for users requiring real-time glucose monitoring.
A major contender backed by a medical device manufacturer, focusing on seamless hardware-to-app data synchronization.
A strong contender that captures the medication adherence segment of the diabetes management workflow.
Same space(3)
Adjacent chronic condition monitoring, focusing on cardiovascular health often comorbid with diabetes.
Adjacent medical utility that captures the financial pain point of diabetes management.
A high-performing symptom tracker that serves as a benchmark for UX in the medical logging category.
New entrants(3)
Recent updates and high activity suggest an emerging focus on comorbid condition tracking.
Leverages deep integration with healthcare provider networks to offer a frictionless patient-to-provider communication experience.
Disrupting the medical space by prioritizing secure, HIPAA-compliant communication between patients and their care teams.
Frequently asked questions
How many apps does Azumio publish?
What kind of apps does Azumio make?
What is Azumio's top app?
In how many countries are Azumio's apps available?
What fed this analysis
- Apps analyzed:
- 2
- With full intel:
- 1
- With overview:
- 2
- Website scraped:
- yes
- Social presence:
- no